Table 1 Clinical characteristics of cholelithiasis with cholecystitis and NC patients.
Charateristics | Test | Train | ||||
|---|---|---|---|---|---|---|
Control | Patient | p-value2 | Control | Patient | p-value2 | |
N = 301 | N = 301 | N = 701 | N = 701 | |||
Gender | 13 (43%) | 16 (53%) | 0.4 | 35 (50%) | 32 (46%) | 0.6 |
Age | 57 ± 15 | 56 ± 14 | 0.8 | 58 ± 15 | 58 ± 15 | 0.8 |
ALT | 23 ± 12 | 37 ± 42 | 0.3 | 30 ± 22 | 74 ± 118 | 0.5 |
AST | 21 ± 5 | 31 ± 49 | 0.8 | 25 ± 14 | 47 ± 67 | 0.7 |
ALB | 47.7 ± 3.0 | 42.4 ± 3.1 | < 0.001 | 46.9 ± 2.4 | 40.4 ± 4.4 | < 0.001 |
TBIL | 17 ± 7 | 15 ± 12 | 0.086 | 15 ± 5 | 23 ± 32 | 0.083 |
DBIL | 3.29 ± 1.27 | 7.90 ± 10.29 | < 0.001 | 3 ± 1 | 16 ± 30 | < 0.001 |
IBIL | 13.6 ± 5.9 | 7.3 ± 3.5 | < 0.001 | 12.3 ± 4.5 | 6.8 ± 4.6 | < 0.001 |
NIT | 0.5 | > 0.9 | ||||
0 | 30 (100%) | 28 (93%) | 69 (99%) | 68 (97%) | ||
1 | 0 (0%) | 2 (6.7%) | 1 (1.4%) | 2 (2.9%) | ||
RPO | 0 (0%) | 2 (6.7%) | 0.5 | 2 (2.9%) | 11 (16%) | 0.009 |
KET | 0 (0%) | 2 (6.7%) | 0.5 | 1 (1.4%) | 7 (10%) | 0.063 |
AFP | 1 (3.3%) | 0 (0%) | > 0.9 | |||
CEA | 0 (0%) | 4 (5.7%) | 0.12 | |||
0 | 30 (100%) | 30 (100%) | ||||
0 | 70 (100%) | 70 (100%) | ||||